T1	Pharmacological_substance 197 216	Isotretinoin-Lidose
T2	Pharmacological_substance 247 259	isotretinoin
N1000 	Reference T2 MeSH:D015474	isotretinoin
T3	Pharmacological_substance 306 318	isotretinoin
N1001 	Reference T3 MeSH:D015474	isotretinoin
T5	Pharmacological_substance 490 502	isotretinoin
N1002 	Reference T5 MeSH:D015474	isotretinoin
T6	Pharmacological_substance 676 688	isotretinoin
N1003 	Reference T6 MeSH:D015474	isotretinoin
T7	Disorder 961 971	depression
N1 	Reference T7 UMLS:C0011570	depression
N2 	Reference T7 UMLS:C0011581	depression
T8	Disorder 973 980	anxiety
N3 	Reference T8 UMLS:C0003469	anxiety
T9	Disorder 991 1009	psychotic symptoms
N4 	Reference T9 UMLS:C0871189	psychotic symptoms
T11	Pharmacological_substance 1845 1857	isotretinoin
N1004 	Reference T11 MeSH:D015474	isotretinoin
T4	Pharmacological_substance 1772 1791	isotretinoin-Lidose
T13	Subject 149 157	patients
T14	Disorder 170 195	recalcitrant nodular acne
T15	Pharmacological_substance 126 145	isotretinoin-Lidose
T17	Pharmacological_substance 1413 1432	isotretinoin-Lidose
T18	Pharmacological_substance 443 462	isotretinoin-Lidose
T19	Subject 551 574	925 randomized patients
T20	Pharmacological_substance 538 550	isotretinoin
N1005 	Reference T20 MeSH:D015474	isotretinoin
T21	Disorder 1015 1041	suicidal ideation/behavior
T22	Disorder 1193 1231	otal nodular facial and truncal lesion
T23	Disorder 1338 1371	nodular facial and truncal lesion
T24	Speculation_cue 88 98	evaluating
